Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997–99)

This publication has 9 references indexed in Scilit:

• Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)
  Clinical Microbiology & Infection, 1999
• Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation
  Diagnostic Microbiology and Infectious Disease, 1999
• Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-μg) diffusion methods
  Diagnostic Microbiology and Infectious Disease, 1999
• Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
  Antimicrobial Agents and Chemotherapy, 1998
• Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]
  Journal of Antimicrobial Chemotherapy, 1997
• Levofloxacin
  Drugs, 1994
• In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone
  Antimicrobial Agents and Chemotherapy, 1994
• Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result
  Diagnostic Microbiology and Infectious Disease, 1993
• In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone
  Antimicrobial Agents and Chemotherapy, 1992